Albiol, N, Moreno, C. Autoimmune Cytopenia in CLL Prognosis and Management in the Era of Targeted Therapies. CANCER JOURNAL. 2021; 27(4)DOI:10.1097/PPO.0000000000000537. PMID:34398555. IF:2.074(Q4/9D).

Esquirol, A, Pascual, MJ, Garcia-Cadenas, I, Herruzo, B, Ferra, C, Perez, A, Torio, A, Torrent, A, Cuesta, M, Martino, R, Sierra, J. Combining Three Different Pretransplantation Scores Improves Predictive Value in Patients after Haploidentical Stem Cell Transplantation with Thiotepa, Busulfan, and Fludarabine Conditioning and Post-Transplantation Cyclophosphamide. Transplantation And Cellular Therapy. 2021; 27(7)DOI:10.1016/j.jtct.2021.03.021. PMID:33775908. IF:(Q/D).

Greil, R, Tedeschi, A, Moreno, C, Anz, B, Larratt, L, Simkovic, M, Gill, D, Gribben, JG, Flinn, IW, Wang, ZY, Cheung, LWK, Nguyen, AN, Zhou, C, Styles, L, Demirkan, F. Pretreatment with ibrutinib reduces cytokine secretion and limits the risk of obinutuzumab-induced infusion-related reactions in patients with CLL: analysis from the iLLUMINATE study. ANNALS OF HEMATOLOGY. 2021; 100(7)DOI:10.1007/s00277-021-04536-6. PMID:34018029. IF:4.030(Q2/5D).

Ribera, JM, Garcia, O, Buendia-Urena, B, Terol, MJ, Vicent, A, Vall-Llovera, F, Bergua, J, Garcia-Cadenas, I, Esteve, J, Ribera, J, Acuna-Cruz, E, Herrera, P, Hernandez-Rivas, JM, Abrisqueta, P, Gonzalez-Campos, J, Rodriguez, C, Bastos-Oreiro, M, Genesca, E, Caminos, N, de Llano, MPQ, Cladera, A, Sancho, JM. Validation of the Burkitt Lymphoma International Prognostic Index in patients treated with two prospective chemoimmunotherapy trials in Spain. LEUKEMIA & LYMPHOMA. 2022; 63(8)DOI:10.1080/10428194.2022.2053531. PMID:35343365. IF:2.600(Q3/7D).

Lopez, S, Martinez-Perez, A, Rodriguez-Rius, A, Vinuela, A, Brown, AA, Martin-Fernandez, L, Vilalta, N, Arus, M, Panousis, NI, Buil, A, Sabater-Lleal, M, Souto, JC, Dermitzakis, ET, Soria, JM. Integrated GWAS and Gene Expression Suggest ORM1 as a Potential Regulator of Plasma Levels of Cell-Free DNA and Thrombosis Risk. THROMBOSIS AND HAEMOSTASIS. 2022; 122(06)DOI:10.1055/s-0041-1742169. PMID:35272364. IF:6.700(Q1/2D).

Bazarbachi, A, Boumendil, A, Finel, H, Khvedelidze, I, Romejko-Jarosinska, J, Tanase, A, Akhtar, S, Ben Othman, T, Ma'koseh, M, Afanasyev, B, Cheikh, J, Briones, J, Gulbas, Z, Hamladji, RM, Elverdi, T, Blaise, D, Martinez, C, Alma, E, Halaburda, K, Sousa, AB, Glass, B, Robinson, S, Montoto, S, Sureda, A. The outcome of patients with Hodgkin lymphoma and early relapse after autologous stem cell transplant has improved in recent years. LEUKEMIA. 2022; 36(6)DOI:10.1038/s41375-022-01563-8. PMID:35414657. IF:11.400(Q1/1D).

Mercadal, S, Alana, M, Barcelo, MI, Bruixola, G, Lopez-Pereira, P, Bobillo, S, Dlouhy, I, Agud, RC, Molina, EG, Martinez, P, Cacabelos, P, Muntanola, A, Garcia-Catalan, G, Sancho, JM, Campos, I, Lado, T, Salar, A, Caballero, AC, Sole-Rodriguez, M, Velasco, R. Ocular involvement in patients with primary central-nervous-system lymphoma: Analysis of a multicentre study in Spain. BRITISH JOURNAL OF HAEMATOLOGY. 2022; 197(6)DOI:10.1111/bjh.18148. PMID:35307813. IF:6.500(Q1/3D).

Hernandez-Boluda, JC, Pereira, A, Zinger, N, Gras, L, Martino, R, Nikolousis, E, Finke, J, Chinea, A, Rambaldi, A, Robin, M, Saccardi, R, Natale, A, Snowden, JA, Tsirigotis, P, Vallejo, C, Wulf, G, Xicoy, B, Russo, D, Maertens, J, Daguindau, E, Lenhoff, S, Hayden, P, Czerw, T, McLornan, DP, Yakoub-Agha, I. Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT (vol 57, pg 416, 2022). BONE MARROW TRANSPLANTATION. 2022; 57(6)DOI:10.1038/s41409-022-01652-3. PMID:35361897. IF:4.800(Q1/2D).